Rabeprazole and Blast cell count increased - a phase IV clinical study of FDA data

Summary:

Blast cell count increased is reported as a side effect among people who take Rabeprazole (rabeprazole sodium), especially for people who are male, 60+ old, have been taking the drug for 1 - 2 years also take Vidaza, and have Acute myeloid leukaemia.

The phase IV clinical study analyzes which people have Blast cell count increased when taking Rabeprazole. It is created by eHealthMe based on reports of 31,196 people who have side effects when taking Rabeprazole from the FDA, and is updated regularly.

What is Rabeprazole?

Rabeprazole has active ingredients of rabeprazole sodium. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 31,689 Rabeprazole users. Check the latest studies of Rabeprazole.

What is Blast cell count increased?

Blast cell count increased is found to be associated with 113 drugs and 180 conditions by eHealthMe. Check the latest studies of Blast cell count increased.

On Jul, 20, 2026

31,196 people reported to have side effects when taking Rabeprazole.
Among them, 12 people (0.04%) have Blast cell count increased.

Could Rabeprazole cause Blast cell count increased?

Among these 12 people:

How long have people been on Rabeprazole when they have Blast cell count increased? *

What is the gender of people who have Blast cell count increased when taking Rabeprazole? *

female: 8.33 %
male: 91.67 %

What is the age of people who have Blast cell count increased when taking Rabeprazole? *

What are other drugs people take besides Rabeprazole? *

Vidaza: 6 people, 50.00%
Itraconazole: 4 people, 33.33%
Prednisolone: 3 people, 25.00%
Allopurinol: 3 people, 25.00%
Daunorubicin Hydrochloride: 3 people, 25.00%
Fragmin: 3 people, 25.00%
Mylotarg: 3 people, 25.00%
Acetaminophen: 3 people, 25.00%
Zosyn: 2 people, 16.67%
Levofloxacin: 2 people, 16.67%

What are other side effects people have besides Blast cell count increased? *

Thrombocytopenia (decrease of platelets in blood): 5 people, 41.67%
White Blood Cell Count Increased: 4 people, 33.33%
Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 4 people, 33.33%
Hyperhidrosis (abnormally increased sweating): 3 people, 25.00%
Hepatic Failure (liver failure): 3 people, 25.00%
Neutrophil Count Decreased (less than normal number of neutrophil a type of blood cell): 3 people, 25.00%
Pleural Effusion (water on the lungs): 3 people, 25.00%
Febrile Neutropenia (fever with reduced white blood cells): 3 people, 25.00%
Renal Impairment (severely reduced kidney function): 3 people, 25.00%
Dizziness: 3 people, 25.00%

What are the existing conditions these people have? *

Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 4 people, 33.33%
Myelodysplastic Syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged): 2 people, 16.67%
Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 2 people, 16.67%
Acute Myeloid Leukaemia Recurrent (acute cancer in which the bone marrow makes abnormal myeloblast- recurrent): 2 people, 16.67%
Urination - Painful: 1 person, 8.33%
Spinal Ligament Ossification (spinal ligament changes into bony substance /hardening): 1 person, 8.33%
Quit Smoking: 1 person, 8.33%
Oral Candidiasis (fungal infection of mouth): 1 person, 8.33%
Oedema (fluid collection in tissue): 1 person, 8.33%
Hypokalemia (low potassium): 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Rabeprazole and have Blast cell count increased?

- Check whether Blast cell count increased is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Rabeprazole:

Rabeprazole (31,689 reports)

Browse all side effects of Rabeprazole:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Blast cell count increased:

Blast cell count increased (113 drugs)

Browse all the conditions that are associated with Blast cell count increased:

Blast cell count increased (180 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on rabeprazole sodium (the active ingredients of Rabeprazole) and Rabeprazole (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.